-
Fetal fibronectin is now being used in many hospitals to separate out those with preterm contractions (PTCs) who are in true labor from those with contractions who are not (and, therefore, not requiring tocolytics or hospitalization).
-
-
In this issue: Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news.
-
Newcomb and colleagues reported breast cancer mortality in the Collaborative Breast Cancer Study Cohort, a prospective cohort of 12,269 postmenopausal women from Wisconsin, Massachusetts, or New Hampshire.
-
-
With the arrival of the Centers for Medicare & Medicaid's no-pay rules, The Joint Commission's National Patient Safety Goals, and the ever-growing emphasis on quality improvement on patient care, prevention has become the name of the game.
-
The Joint Commission requires a "thorough and credible" root cause analysis (RCA) for all Sentinel Events, but the process is sometimes less effective than hoped. Quality leaders at the Mayo Clinic came up with a novel solution: An oversight group to keep the process on track.
-
Several states are re-energizing hospital board member education efforts with moves to certify and mandate educational requirements. Minnesota has started a voluntary certification program, and New Jersey has passed laws to require education.
-
Dubbed the "Patients' Right to Know Amendment," Florida's Amendment 7 has hospital watchdogs and consumer rights groups up in arms about what is constitutional and what should be revealed about hospitals' peer review records.
-
Joint Commission announced it is launching a campaign to help people work with their care providers in managing pain.
